Skip to main content
Figure 2 | BMC Veterinary Research

Figure 2

From: A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain

Figure 2

Change in LOAD scores over time in dogs administered anti-NGF antibody or placebo. a. Change from baseline in LOAD (median [solid line], interquartile range [shaded area] and extreme values [whiskers]) in dogs treated with a single 200 mcg/kg intravenous injection of anti-NGF antibody on D0. b. Change from baseline in LOAD (median [solid line], interquartile range [shaded area] and extreme values [whiskers]) in dogs treated with a single intravenous injection of placebo (saline) on D0.

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us